DEA Classifies Three Steroids
The U.S. Drug Enforcement Agency (DEA; Springfield, VA) announced that it has classified boldione, desoxymethyltestosterone, and 19-nor-4,9(10)-androstadienedione as anabolic steroids under the Controlled Substances Act, according to the Natural Products Association (NPA; Washington, DC). This ruling will be made effective January 4, 2010.
The U.S. Drug Enforcement Agency (DEA; Springfield, VA) announced that it has classified boldione, desoxymethyltestosterone, and 19-nor-4,9(10)-androstadienedione as anabolic steroids under the Controlled Substances Act, according to the Natural Products Association (NPA; Washington, DC). This ruling will be made effective January 4, 2010.
NPA released a press release, last week, commending the action by DEA. 'The association has maintained all along that federal regulators have the authority they need [to schedule these substances],'ÃÂ said John Gay, executive director and CEO of NPA. 'The DEA...s listing of these three steroids demonstrates that federal regulators can indeed safeguard the shelves against these substances.'ÃÂ
The classified substances received increased scrutiny during talks at a September Senate hearing on 'hidden steroids'ÃÂ held by the Senate Subcommittee on Crime and Drugs. DEA first received notice for proposed rulemaking on the substances in April 2008. The agency also states that, since August 2008, it has been aware of 58 dietary supplements believed to contain one or more of these substances.
DEA...s full announcement can be read here
Judge denies CRN’s motion for preliminary injunction but its lawsuit against NY state will proceed
April 23rd 2024The judge in CRN's lawsuit against NY state's law banning the sale of weight management and muscle building supplements to minors has denied its motion for a preliminary injunction, but determined that CRN has standing to sue on behalf of its members.
The Nutritional Outlook Podcast Episode 29: 2024 Ingredients to Watch
January 31st 2024Nutritional Outlook interviews Scott Dicker, market insights director from market researcher SPINS, about ingredients and product categories nutraceutical and nutrition product manufacturers should watch in 2024.
